Daniel Bee Email & Phone Number

Newton Abbot, Devon, GB

Novel POCT digital diagnostic technology

Flémalle-Grande, Walloon Region, BE

Revolutionising bone regeneration for dental surgery through the development of superior bone graft technologies

Cambridge, GB

Wellcome Sanger Institute - The world's largest and most comprehensive resource for exploring the impact of somatic mutations in human cancer.

Bourton On The Water, England, GB

• A global manufacturer and innovator of proprietary sterile, single use orthopaedic, sports medicine and surgical devices. Commercial partnerships with multiple Global OEMs
• Attained UK, Germany, USA and International market leadership in multiple product categories.M&A and rapid organic growth.
• Trade sales of two non-core French and German manufacturing subsidiariesFund-raising and exit
• Fund-raising – led two bank refinancing processesLed exit for The Riverside Company via an SBO, supported by Apposite Capital, March 2018.

• UK independent distributor sales to spine and orthopaedic surgical markets
• Rapid revenue growth - attained market leadership in neonatal spine implants.
• Secured an exit for LivingBridge Private Equity.

London, GB

Advising BBC Dragon James Caan’s portfolio companies to maximise growth and optimise exit value.

Kuala Lumpur, MY

• Angel investment backed R&D biotech company
• Led the full commercial roll-out - established international sales across EU and Far East
• Secured a trade sale to a global pharmaceutical company (InQpharm)

Bourton On The Water, England, GB

Advised on commercial strategy and conducted commercial DD on a number of overseas M&A targets

Malvern, PA, US

• Biotech and digital health company focused on developing and commercialising proprietary biocides that safely, effectively, and naturally kill contagious pathogens.
• UK and International growth – 330% sales growth in 48 months
• Achieved growth through NPD and cultivating a high-performing, customer-centric sales team.
• M&A - acquisition and integration of Labcaire Ltd
• Secured a cross-border strategic exit for the entire UK trading entity.

Lewisville, TX, US

• UK & International Commercial growth - Anaesthesia, neo-natal, orthopaedics
• $220m P&L Accountability
• Recovered market leadership through strategic re-orientation and a instilling a confident, sales driven culture.- Investors in People Award

Boston, MA, US

Cardiovascular & Haematology - donor and surgical automated blood processing technology - 174% sales growth - 48 months of successive quarter on quarter growth- 740% EBITDA growth- 33% return on Sales (up from 8% return on sales in 2001)- Exceeded revenue and EBITDA targets for 16 consecutive quarters

Lakewood, Colorado, US

• Blood component and Digital Health Spin-out from SAAB Aerospace (Sweden)
• Medical Technology Spin-out from SAAB Aerospace
• Led the International commercialisation of the business across Europe, Australia and USA.
• Secured a strategic exit to Gambro BCT

Bourton On The Water, England, GB

• Surgical, orthopaedic, spinal implant, wound care and blood products.
• 14x revenue growth through NPD, manufacturing and commercial agreements with global partners.

Fellowship, Chartered Marketeer

Bachelor'S Degree, Business And Finance

Education record

Chartered Director, Diploma In Company Direction

Education record